{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:55:23Z","timestamp":1778860523220,"version":"3.51.4"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T00:00:00Z","timestamp":1728691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T00:00:00Z","timestamp":1728691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"DOI":"10.1186\/s13643-024-02675-1","type":"journal-article","created":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T06:03:58Z","timestamp":1728713038000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy of pharmacological interventions for ADHD: protocol for an updated systematic review and dose\u2013response network meta-analysis"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0952-0091","authenticated-orcid":false,"given":"Mikail","family":"Nourredine","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucie","family":"Jurek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgia","family":"Salanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabien","family":"Subtil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orestis","family":"Efthimiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tasnim","family":"Hamza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuele","family":"Cortese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,12]]},"reference":[{"key":"2675_CR1","doi-asserted-by":"publisher","first-page":"947 p.","DOI":"10.1176\/appi.books.9780890425596","volume-title":"American psychiatric association, \u00e9diteurs. diagnostic and statistical manual of mental disorders: DSM-5","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. American psychiatric association, \u00e9diteurs. diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Washington, D.C: American Psychiatric Association; 2013. p. 947 p.","edition":"5"},{"issue":"1","key":"2675_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41572-024-00495-0","volume":"10","author":"SV Faraone","year":"2024","unstructured":"Faraone SV, Bellgrove MA, Brikell I, Cortese S, Hartman CA, Hollis C, et al. Attention-deficit\/hyperactivity disorder. Nat Rev Dis Primer. 2024;10(1):11.","journal-title":"Nat Rev Dis Primer."},{"issue":"2","key":"2675_CR3","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1017\/S003329170500471X","volume":"36","author":"SV Faraone","year":"2006","unstructured":"Faraone SV, Biederman J, Mick E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med. 2006;36(2):159\u201365.","journal-title":"Psychol Med"},{"key":"2675_CR4","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.neubiorev.2021.01.022","volume":"128","author":"SV Faraone","year":"2021","unstructured":"Faraone SV, Banaschewski T, Coghill D, Zheng Y, Biederman J, Bellgrove MA, et al. The world federation of ADHD international consensus statement: 208 evidence-based conclusions about the disorder. Neurosci Biobehav Rev. 2021;128:789\u2013818.","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"2675_CR5","doi-asserted-by":"publisher","first-page":"130","DOI":"10.7326\/0003-4819-159-2-201307160-00008","volume":"159","author":"A Cipriani","year":"2013","unstructured":"Cipriani A, Higgins JPT, Geddes JR, Salanti G. Conceptual and technical challenges in network meta-analysis. Ann Intern Med. 2013;159(2):130.","journal-title":"Ann Intern Med"},{"issue":"2","key":"2675_CR6","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1136\/eb-2015-102088","volume":"18","author":"D Mavridis","year":"2015","unstructured":"Mavridis D, Giannatsi M, Cipriani A, Salanti G. A primer on network meta-analysis with emphasis on mental health. Evid Based Ment Health mai. 2015;18(2):40\u20136.","journal-title":"Evid Based Ment Health mai"},{"issue":"9","key":"2675_CR7","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S2215-0366(18)30269-4","volume":"5","author":"S Cortese","year":"2018","unstructured":"Cortese S, Adamo N, Del Giovane C, Mohr-Jensen C, Hayes AJ, Carucci S, et al. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry. 2018;5(9):727\u201338.","journal-title":"Lancet Psychiatry"},{"issue":"4","key":"2675_CR8","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.jaac.2016.02.001","volume":"55","author":"WB Brinkman","year":"2016","unstructured":"Brinkman WB, Baum R, Kelleher KJ, Peugh J, Gardner W, Lichtenstein P, et al. Relationship between attention-deficit\/hyperactivity disorder care and medication continuity. J Am Acad Child Adolesc Psychiatry. 2016;55(4):289\u201394.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"6","key":"2675_CR9","doi-asserted-by":"publisher","first-page":"e20172580","DOI":"10.1542\/peds.2017-2580","volume":"141","author":"WB Brinkman","year":"2018","unstructured":"Brinkman WB, Sucharew H, Majcher JH, Epstein JN. Predictors of medication continuity in children with ADHD. Pediatrics. 2018;141(6):e20172580.","journal-title":"Pediatrics"},{"issue":"1","key":"2675_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/CHI.0b013e31818b1c8f","volume":"48","author":"M Olfson","year":"2009","unstructured":"Olfson M, Marcus S, Wan G. Stimulant dosing for children with ADHD: a medical claims analysis. J Am Acad Child Adolesc Psychiatry. 2009;48(1):51\u20139.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"3","key":"2675_CR11","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/00004583-200303000-00007","volume":"42","author":"SR Pliszka","year":"2003","unstructured":"Pliszka SR, Lopez M, Crismon ML, Toprac MG, Hughes CW, Emslie GJ, et al. A feasibility study of the Children\u2019s Medication Algorithm Project (CMAP) algorithm for the treatment of ADHD. J Am Acad Child Adolesc Psychiatry. 2003;42(3):279\u201387.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"2675_CR12","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12887-023-03850-4","volume":"23","author":"Y Xu","year":"2023","unstructured":"Xu Y, Chung H, Shu M, Liu Y, Zhang Y, Qiu H. Dose titration of osmotic release oral system methylphenidate in children and adolescents with attention-deficit hyperactivity disorder: a retrospective cohort study. BMC Pediatr. 2023;23(1):38.","journal-title":"BMC Pediatr"},{"issue":"1","key":"2675_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/ebmental-2021-300278","volume":"25","author":"T Hamza","year":"2022","unstructured":"Hamza T, Furukawa TA, Orsini N, Cipriani A, Salanti G. Dose\u2013effect meta-analysis for psychopharmacological interventions using randomised data. Evid Based Ment Health. 2022;25(1):1\u20136.","journal-title":"Evid Based Ment Health"},{"issue":"8","key":"2675_CR14","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/psp4.12091","volume":"5","author":"D Mawdsley","year":"2016","unstructured":"Mawdsley D, Bennetts M, Dias S, Boucher M, Welton N. Model-based network meta-analysis: a framework for evidence synthesis of clinical trial data: model-based network meta-analysis. CPT Pharmacomet Syst Pharmacol. 2016;5(8):393\u2013401.","journal-title":"CPT Pharmacomet Syst Pharmacol"},{"key":"2675_CR15","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"28","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;28:l4898.","journal-title":"BMJ"},{"issue":"3","key":"2675_CR16","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1038\/s41380-021-01391-9","volume":"27","author":"LC Farhat","year":"2022","unstructured":"Farhat LC, Flores JM, Behling E, Avila-Quintero VJ, Lombroso A, Cortese S, et al. The effects of stimulant dose and dosing strategy on treatment outcomes in attention-deficit\/hyperactivity disorder in children and adolescents: a meta-analysis. Mol Psychiatry. 2022;27(3):1562\u201372.","journal-title":"Mol Psychiatry"},{"key":"2675_CR17","doi-asserted-by":"publisher","unstructured":"Hamza T, Furukawa TA, Orsini N, Cipriani A, Iglesias CP, Salanti G. A dose\u2013effect network meta-analysis model with application in antidepressants using restricted cubic splines. Stat Methods Med Res. 2022;33(8):096228022110702. https:\/\/doi.org\/10.1177\/09622802211070256.","DOI":"10.1177\/09622802211070256"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-024-02675-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13643-024-02675-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-024-02675-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T06:04:45Z","timestamp":1728713085000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-024-02675-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,12]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2675"],"URL":"https:\/\/doi.org\/10.1186\/s13643-024-02675-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4342181\/v1","asserted-by":"object"}]},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,12]]},"assertion":[{"value":"29 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"M. N., L. J., G. S., A. C., F. S., O. E., and T. H. declare that they have no competing interests. S. C. has declared reimbursement for travel and accommodation expenses from the Association for Child and Adolescent Central Health (ACAMH) in relation to lectures delivered for ACAMH, the Canadian AADHD Alliance Resource, the British Association of Psychopharmacology, and from Healthcare Convention for educational activity on ADHD and has received honoraria from Medice","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"256"}}